Home Antimicrobial Resistance and Alternatives to Antimicrobials [Lytic Phage] – Phage as an adjunct to other therapies – Phage
Antimicrobial Resistance and Alternatives to Antimicrobials roadmap:
Control Strategies

Roadmap for Phage technologies

Download Alternatives-to-Antibiotics-Report-2022

3

Lytic Phage

Phage as an adjunct to other therapies

Research Question

What are we trying to achieve and why? What is the problem we are trying to solve?

To understand if phage and antibiotics can be used together to generate synergistic effect and reduce/counteract resistance.

Research Gaps and Challenges

What are the scientific and technological challenges (knowledge gaps needing to be addressed)?

Identify receptors sites (e.g. binding efflux pumps).
Investigate interaction among phages and antibiotics.
Understanding the adaptation of phages to immune systems.
Characterization of phage resistance in bacteria and fitness costs of bacteria (resistant bacteria may be more susceptible to AB and the immune response).
Use of phages to block transmission of AMR plasmids (phages could be used to cut antibiotic resistant genes and plasmids).

Solution Routes

What approaches could/should be taken to address the research question?

In vitro and in vivo evaluation.
Crisp-Cas system in the bacteria – can they show immunity to the phages.

Dependencies

What else needs to be done before we can solve this need?

 

State Of the Art

Existing knowledge including successes and failures

 

Projects

What activities are planned or underway?

Advanced porous materials for antimicrobial treatment

Planned Completion date 31/10/2023

Participating Country(s):

NetherlandsIconNetherlands

outer membrane vesicles protect gram negative bacteria against host defense peptides

Planned Completion date 25/08/2021

Participating Country(s):

NetherlandsIconNetherlands